SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following FDA approval of its oral Wegovy, making it the first GLP-1 pill for weight management. The community sees this as a major catalyst, providing a convenient alternative to injections and positioning Novo Nordisk with a crucial edge in the rapidly expanding obesity treatment market against rivals like Eli Lilly. Investors are closely watching its market impact.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing a powerful, near-parabolic rally to fresh all-time highs, fueled by escalating industrial demand from sectors like EV batteries and clean energy, alongside looming Chinese export restrictions tightening global supply. This has sparked intense debate among investors, with many anticipating a monumental short squeeze and continued price discovery, while others caution the asset is severely overbought and due for a significant pullback.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending as its merger target, Infleqtion, garners significant attention for its leadership in quantum sensing and defense applications, including recent partnerships with Safran and collaborations with NVIDIA. The community sees Infleqtion as a highly undervalued quantum play with real revenue and critical national security utility, anticipating a substantial re-rating post-merger as institutional capital flows in.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. (SOC) is actively trending following news of federal regulatory approval for its Las Flores Pipeline restart, shifting oversight from California to federal authority. This development is largely seen by the community as a significant de-risking event, fueling bullish sentiment and sparking discussions of a potential short squeeze given the stock's high short interest. Traders are anticipating substantial upside as this milestone paves the way for resuming offshore oil production.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is currently trending due to a series of recent teaming agreements and product evaluations for its advanced thin-film photovoltaic modules, specifically for space and defense applications. The community is highly engaged, with many anticipating significant contracts and long-term growth in the burgeoning space economy, while a skeptical contingent highlights historical issues of dilution and speculative trading patterns.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent reports of high-grade silver drill results from its exploration program, coinciding with a broader rally in precious metals prices. The community is actively discussing the potential for a short squeeze and significant long-term appreciation, especially given major investor Eric Sprott's continued share acquisitions. However, some cautionary voices highlight concerns about the stock's current valuation and the possibility of future share offerings.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is actively trending due to significant community discussion surrounding the federal reclassification of cannabis to Schedule III, an event widely seen as a major catalyst for the industry. The community is rallying behind tokens like $WEEDCOIN, leveraging Solana's high-speed network to champion a 'Green Revolution' aimed at disrupting pharmaceutical monopolies and attracting substantial capital on-chain. This strong narrative positions Solana as the preferred platform for this cultural and financial paradigm shift.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is generating significant buzz due to extreme price volatility, fueling a fierce community debate. Bulls point to its low float and high shorting fees, anticipating a massive short squeeze, while skeptics warn of a pump-and-dump given its pre-revenue status and high market valuation. The ongoing battle between buyers and sellers, coupled with calls of market manipulation, keeps this aerospace-related ticker actively discussed.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is garnering significant attention following a successful $20 million offering and key milestones, including graduating Shell's GameChanger program and validating its hydrochemolytic process for converting waste plastics into high-value oils. This has sparked a polarized community debate, with many investors highlighting these advancements and new partnerships as strong indicators of future growth in the circular plastics market. Conversely, skeptics question the company's valuation and economic viability at scale, despite the technological progress.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience (RGC) is attracting significant attention, fueled by its extremely low share float and substantial insider ownership, which is sparking community discussions about a potential short squeeze. Traders are actively tracking its high cost to borrow and anticipating a surge, drawing comparisons to its past explosive runs despite acknowledged speculative fundamentals.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ADMA Biologics Inc $ADMA Shares Bought by Voya Investment Management LLC

Voya Investment Management LLC lifted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 3.9% during the third quarter, according to its most recent Form 13F filing with the...

Texas Permanent School Fund Corp Has $1.87 Million Holdings in ADMA Biologics Inc $ADMA

Texas Permanent School Fund Corp trimmed its stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 39.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and...

Perpetual Ltd Cuts Stake in ADMA Biologics Inc $ADMA

Perpetual Ltd cut its stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 26.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,119,291...

Thrivent Financial for Lutherans Raises Stock Holdings in ADMA Biologics Inc $ADMA

Thrivent Financial for Lutherans increased its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 78.1% in the second quarter, according to its most recent filing with the SEC...

ADMA Biologics Inc $ADMA Shares Purchased by Ranger Investment Management L.P.

Ranger Investment Management L.P. boosted its stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 49.1% during the second quarter, according to its most recent 13F filing with the Securities...

Cim LLC Acquires New Holdings in ADMA Biologics Inc $ADMA

Cim LLC bought a new stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange...

Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year?

Here is how Adma Biologics (ADMA) and Artivion (AORT) have performed compared to their sector so far this year.

Osterweis Capital Management Inc. Takes $5.40 Million Position in ADMA Biologics Inc $ADMA

Osterweis Capital Management Inc. bought a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) in the second quarter, according to the company in its most recent Form 13F filing...

ADMA Biologics Inc $ADMA Shares Purchased by Marathon Capital Management

Marathon Capital Management boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 82.9% in the second quarter, according to its most recent disclosure with the SEC. The...

WINTON GROUP Ltd Has $4.97 Million Stock Position in ADMA Biologics Inc $ADMA

WINTON GROUP Ltd raised its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 302.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Current Price	$19.93
Prev Close	$19.58
Open	$19.58
Dividend Yield	0.00%
50-Day Moving Average	$16.97
Beta	1.27
Avg. Volume	4.02M
PE Ratio	23.35

52-Week High	$25.67
52-Week Low	$13.50
Market Capitalization	$4.73B
EPS (Annual)	$0.8123
Price to Book	10.99
Revenue Per Employee	$622,560.58
Enterprise Value/EBITDA	N/A

ADMA
Adma Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADMA News

ADMAAdma Biologics Inc